Novartis Defeats Appeal To Bone Drug Bellwether Ruling
An appeals court on Wednesday upheld judgments for Novartis Pharmaceuticals Corp. in the first bellwether trial in consolidated litigation in New Jersey over claims the drugmaker's bone cancer drugs Aredia and...To view the full article, register now.
Already a subscriber? Click here to view full article